PACIFIC BIOSCIENCES OF CALIF (PACB)

PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The rock star money manager is starting to roll with the rallying market.

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

Priced at just $169,000 Vega is designed to make highly accurate long-read sequencing accessible to any laboratory...

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

/PRNewswire/ -- Volta Labs™, a genomics applications company, announced today that it has joined the PacBio Compatible program, further expanding the...

PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT Cell, improves methylation...

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

MENLO PARK, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate genomic sequencing...

PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing

Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia...

PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024

MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss...

PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore

The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in...

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms,...

PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific

Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss...

Commit To Purchase Pacific Biosciences of California At $1, Earn 43.5% Annualized Using Options

Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital

Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male...

PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024

PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

PacBio Announces Second Quarter 2024 Financial Results

MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. ...

Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia

This joint effort will harness PacBio's state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms,...

PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm

Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing

Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research...